Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -17.30-30.27-56.94-32.73-55.53

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -17.30 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73
Mar2020-55.53

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73
Negative
Mar2020 -55.53 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹183.6 Cr 2.7% -16.7% 19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
DIVIS LABORATORIES ₹158,655.0 Cr 2.4% 2.2% 59.7% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

2.7%

-16.7%

19.7%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses